Literature DB >> 11024280

Subtractive hybridization identifies chick-cripto, a novel EGF-CFC ortholog expressed during gastrulation, neurulation and early cardiogenesis.

J F Colas1, G C Schoenwolf.   

Abstract

EGF-CFC genes encode a novel class of extracellular, membrane-associated proteins that notably play an important role during vertebrate gastrulation. Whereas the two cysteine-rich domains that characterize these proteins, namely the extracellular EGF-like and the CFC domain, are known to be encoded by two evolutionarily conserved exons, it is generally assumed, based on weak primary sequence identity, that the remaining parts of the protein differ among vertebrates, suggesting that known members of the EGF-CFC family do not represent true orthologs. Here, by characterizing the full cDNA and genomic sequences of a new EGF-CFC gene in chick, and by comparing them with their counterparts in human (CRIPTO), mouse (cripto and cryptic), Xenopus (FRL-1) and zebrafish (one-eyed pinhead), we show that all EGF-CFC genes share an identical genomic organization over the entire coding region. Not only are the central two exons (coding for the EGF-like and CFC motifs) conserved, but also conserved are the total number of exons, their size, their intron phase and their correlation with discrete protein modules, in particular those modules that allow the EGF-CFC motif to become membrane-associated. Therefore, despite apparent divergence between their 5' and 3'-terminal exons, all known CRIPTO-related genes are structurally orthologous. We named this novel ortholog in bird, chick-cripto. We report the mRNA distribution of chick-cripto, which begins in the epiblast of the gastrula, with a pattern similar to EGF-CFC genes of other vertebrates.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11024280     DOI: 10.1016/s0378-1119(00)00337-1

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  7 in total

Review 1.  Targeting the embryonic gene Cripto-1 in cancer and beyond.

Authors:  Caterina Bianco; David S Salomon
Journal:  Expert Opin Ther Pat       Date:  2010-11-13       Impact factor: 6.674

2.  Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial Cells.

Authors:  Caterina Bianco; Heather B Adkins; Christian Wechselberger; Masaharu Seno; Nicola Normanno; Antonella De Luca; Youping Sun; Nadia Khan; Nicholas Kenney; Andreas Ebert; Kevin P Williams; Michele Sanicola; David S Salomon
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

3.  A role for Vg1/Nodal signaling in specification of the intermediate mesoderm.

Authors:  Britannia M Fleming; Ronit Yelin; Richard G James; Thomas M Schultheiss
Journal:  Development       Date:  2013-04       Impact factor: 6.868

Review 4.  Spina Bifida: Pathogenesis, Mechanisms, and Genes in Mice and Humans.

Authors:  Siti W Mohd-Zin; Ahmed I Marwan; Mohamad K Abou Chaar; Azlina Ahmad-Annuar; Noraishah M Abdul-Aziz
Journal:  Scientifica (Cairo)       Date:  2017-02-13

5.  Cripto promotes A-P axis specification independently of its stimulatory effect on Nodal autoinduction.

Authors:  Daniela D'Andrea; Giovanna L Liguori; J Ann Le Good; Enza Lonardo; Olov Andersson; Daniel B Constam; Maria G Persico; Gabriella Minchiotti
Journal:  J Cell Biol       Date:  2008-02-11       Impact factor: 10.539

6.  Cripto haploinsufficiency affects in vivo colon tumor development.

Authors:  Emilia Giorgio; Annamaria Liguoro; Luca D'Orsi; Sara Mancinelli; Antonio Barbieri; Giuseppe Palma; Claudio Arra; Giovanna L Liguori
Journal:  Int J Oncol       Date:  2014-04-30       Impact factor: 5.650

7.  Exogenous Cripto-1 Suppresses Self-Renewal of Cancer Stem Cell Model.

Authors:  Md Jahangir Alam; Ryota Takahashi; Said M Afify; Aung Ko Ko Oo; Kazuki Kumon; Hend M Nawara; Aprilliana Cahya Khayrani; Juan Du; Maram H Zahra; Akimasa Seno; David S Salomon; Masaharu Seno
Journal:  Int J Mol Sci       Date:  2018-10-26       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.